Constellium (CSTM) Financials

$12.24 -0.06 (-0.45%)

Closing price 05/28/2025 03:59 PM Eastern

Extended Trading

$12.23 -0.01 (-0.12%)

As of 04:45 AM Eastern

Annual Income Statements for Constellium

This table shows Constellium's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	56	152	308	291	-26	77	220	-37	-4.21	-600
Consolidated Net Income / (Loss)	60	157	315	297	-21	72	217	-37	-4.21	-600
Net Income / (Loss) Continuing Operations	60	157	315	297	-21	72	217	-37	-4.21	-600
Total Pre-Tax Income	135	232	150	359	-42	92	254	59	68	-635
Total Operating Income	272	386	343	548	153	312	287	322	259	-463
Total Gross Profit	938	1,055	963	752	599	676	616	667	563	489
Total Revenue	7,335	7,826	8,532	6,963	5,965	6,629	6,508	6,291	4,990	5,431
Operating Revenue	7,335	7,826	8,532	6,963	5,965	6,629	6,508	6,291	4,990	5,431
Total Cost of Revenue	6,397	6,771	7,569	6,211	5,367	5,954	5,892	5,624	4,427	5,110
Operating Cost of Revenue	6,397	6,771	7,569	6,211	5,367	5,954	5,892	5,624	4,427	5,110
Total Operating Expenses	666	669	620	204	446	364	328	345	304	809
Selling, General & Admin Expense	313	317	284	292	290	310	283	297	266	266
Research & Development Expense	49	52	46	44	48	54	46	43	33	38
Depreciation Expense	304	300	290	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-137	-154	-193	-189	-194	-220	-33	-263	-190	-142
Interest Expense	111	111	103	-	-	194	208	312	198	-
Other Income / (Expense), net	-26	-43	-90	-	-	-26	175	84	22	-142
Income Tax Expense	75	75	-165	62	-21	20	37	96	73	-35
Net Income / (Loss) Attributable to Noncontrolling Interest	4.00	5.00	7.00	-5.66	-4.89	-5.61	-2.29	0.00	0.00	-
Basic Earnings per Share	$0.38	$1.04	$2.14	$1.82	($0.15)	$0.43	$1.40	($0.28)	($0.04)	-
Weighted Average Basic Shares Outstanding	143.52M	146.82M	144.30M	141.00M	138.74M	136.86M	134.76M	134.51M	-	-
Diluted Earnings per Share	$0.38	$1.03	$2.10	$1.75	($0.15)	$0.41	$1.37	($0.28)	($0.04)	-
Weighted Average Diluted Shares Outstanding	143.52M	146.82M	144.30M	147.17M	138.74M	142.65M	138.15M	134.51M	-	-
Weighted Average Basic & Diluted Shares Outstanding	143.52M	146.82M	144.30M	141.68M	139.96M	137.87M	136.00M	134.51M	-	-

This table shows Constellium's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025
Period end date	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	37
Consolidated Net Income / (Loss)	38
Net Income / (Loss) Continuing Operations	38
Total Pre-Tax Income	62
Total Operating Income	94
Total Gross Profit	263
Total Revenue	1,979
Operating Revenue	1,979
Total Cost of Revenue	1,716
Operating Cost of Revenue	1,716
Total Operating Expenses	169
Selling, General & Admin Expense	78
Research & Development Expense	13
Depreciation Expense	78
Total Other Income / (Expense), net	-32
Interest Expense	27
Other Income / (Expense), net	-5.00
Income Tax Expense	24
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00
Basic Earnings per Share	$0.26
Weighted Average Basic Shares Outstanding	142.92M
Diluted Earnings per Share	$0.26
Weighted Average Diluted Shares Outstanding	142.92M
Weighted Average Basic & Diluted Shares Outstanding	142.92M

This table details how cash moves in and out of Constellium's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-73	39	19	-338	316	20	-122	-85	-139	-827
Net Cash From Operating Activities	301	432	365	404	408	502	76	192	93	-600
Net Cash From Continuing Operating Activities	301	432	365	404	408	502	76	192	93	-600
Net Income / (Loss) Continuing Operations	60	157	315	297	-21	72	217	-37	-4.21	-600
Consolidated Net Income / (Loss)	60	157	315	297	-21	72	217	-37	-4.21	-600
Depreciation Expense	304	300	290	302	316	287	225	205	163	-
Non-Cash Adjustments To Reconcile Net Income	73	53	-82	238	186	155	66	360	203	-
Changes in Operating Assets and Liabilities, net	-136	-78	-158	-432	-73	-12	-434	-336	-269	-
Net Cash From Investing Activities	-313	-216	-196	-250	-215	-396	-104	-351	-384	4.35
Net Cash From Continuing Investing Activities	-313	-216	-196	-250	-215	-396	-104	-351	-384	4.35
Purchase of Property, Plant & Equipment	-413	-366	-289	-	-	-	-	-	-	-
Acquisitions	3.00	0.00	0.00	-	-	-93	0.00	0.00	22	-
Divestitures	0.00	51	0.00	-	-	-	-	-	-	4.35
Other Investing Activities, net	97	99	93	0.00	0.00	-1.12	-16	-22	-27	-
Net Cash From Financing Activities	-61	-177	-150	-492	123	-85	-94	73	153	-231
Net Cash From Continuing Financing Activities	-61	-177	-150	-492	123	-85	-94	73	153	-231
Repayment of Debt	-640	-155	-130	-1,191	-255	-117	-1.14	-1,873	-156	-229
Repurchase of Common Equity	-79	0.00	0.00	-	-	-	-	-	-	-
Payment of Dividends	-5.00	-3.00	-2.00	-2.26	0.00	-4.49	0.00	0.00	-2.10	-
Issuance of Debt	671	0.00	0.00	800	442	127	-77	1,765	322	-
Other Financing Activities, net	-8.00	-19	-18	-100	-64	-91	-16	-130	-12	-2.17

This table details how cash moves in and out of Constellium's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025
Period end date	3/31/2025
Net Change in Cash & Equivalents	-27
Net Cash From Operating Activities	58
Net Cash From Continuing Operating Activities	58
Net Income / (Loss) Continuing Operations	38
Consolidated Net Income / (Loss)	38
Depreciation Expense	78
Non-Cash Adjustments To Reconcile Net Income	24
Changes in Operating Assets and Liabilities, net	-82
Net Cash From Investing Activities	-59
Net Cash From Continuing Investing Activities	-59
Purchase of Property, Plant & Equipment	-69
Other Investing Activities, net	10
Net Cash From Financing Activities	-26
Net Cash From Continuing Financing Activities	-26
Repayment of Debt	-7.00
Repurchase of Common Equity	-15
Payment of Dividends	-2.00
Other Financing Activities, net	-2.00

This table presents Constellium's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	4,734	4,933	5,286	5,233	5,044	4,696	4,465	4,458	3,984
Total Current Assets	1,834	1,992	787	3,198	1,791	1,515	1,649	1,682	1,483
Cash & Equivalents	141	223	178	166	536	206	188	323	365
Accounts Receivable	486	531	577	773	496	532	672	503	373
Inventories, net	1,181	1,197	-	2,193	711	752	755	772	622
Other Current Assets	26	41	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	2,408	2,422	0.00	2,205	2,328	2,307	1,907	1,822	1,554
Total Noncurrent Assets	492	519	929	835	925	873	909	954	947
Noncurrent Note & Lease Receivables	36	34	-	-	-	-	-	-	-
Goodwill	46	41	511	510	509	511	483	484	481
Intangible Assets	97	104	58	66	75	79	80	82	83
Noncurrent Deferred & Refundable Income Taxes	311	337	290	183	236	275	260	197	265
Other Noncurrent Operating Assets	2.00	3.00	55	76	105	7.86	85	190	101
Total Liabilities & Shareholders' Equity	4,734	4,933	5,286	5,233	5,044	4,696	4,465	4,458	3,984
Total Liabilities	4,007	4,191	4,481	4,904	5,167	4,791	4,595	4,841	4,584
Total Current Liabilities	1,446	1,556	1,822	1,940	1,327	1,428	1,201	1,333	1,075
Short-Term Debt	39	41	202	292	112	226	-	127	113
Accounts Payable	1,309	1,411	1,592	1,558	1,106	1,121	1,139	1,117	883
Current Deferred & Payable Income Tax Liabilities	18	22	-	38	24	16	9.16	13	-
Current Employee Benefit Liabilities	22	24	-	-	-	-	-	-	-
Other Current Liabilities	58	58	-	51	84	65	53	76	80
Total Noncurrent Liabilities	2,561	2,635	2,660	2,964	3,841	3,363	3,395	3,508	3,495
Long-Term Debt	1,879	1,888	2,056	2,118	2,808	2,424	2,462	2,428	2,484
Noncurrent Deferred & Payable Income Tax Liabilities	39	35	30	16	12	27	25	30	32
Noncurrent Employee Benefit Liabilities	375	431	431	678	811	752	698	798	773
Other Noncurrent Operating Liabilities	268	281	142	153	209	160	209	252	206
Commitments & Contingencies	0.00	0.00	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	727	742	804	329	-123	-95	-130	-383	-600
Total Preferred & Common Equity	706	718	782	310	-264	-95	-140	-393	-609
Total Common Equity	706	718	333	-165	-654	-579	-140	-393	-609
Common Stock	517	517	3.21	3.40	3.66	3.37	3.43	3.60	2.10
Accumulated Other Comprehensive Income / (Loss)	-14	0.00	-	-	-	-	-	-	-
Other Equity Adjustments	203	201	329	-169	-657	-	-143	505	170
Noncontrolling Interest	21	24	22	19	17	12	9.16	9.61	9.47

This table presents Constellium's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025
Period end date	3/31/2025
Total Assets	5,168
Total Current Assets	2,236
Cash & Equivalents	118
Accounts Receivable	818
Inventories, net	1,278
Other Current Assets	22
Plant, Property, & Equipment, net	2,456
Total Noncurrent Assets	476
Noncurrent Note & Lease Receivables	38
Goodwill	46
Intangible Assets	94
Noncurrent Deferred & Refundable Income Taxes	294
Other Noncurrent Operating Assets	4.00
Total Liabilities & Shareholders' Equity	5,168
Total Liabilities	4,403
Total Current Liabilities	1,808
Short-Term Debt	35
Accounts Payable	1,665
Current Deferred & Payable Income Tax Liabilities	17
Current Employee Benefit Liabilities	23
Other Current Liabilities	68
Total Noncurrent Liabilities	2,595
Long-Term Debt	1,908
Noncurrent Deferred & Payable Income Tax Liabilities	48
Noncurrent Employee Benefit Liabilities	377
Other Noncurrent Operating Liabilities	262
Commitments & Contingencies	0.00
Total Equity & Noncontrolling Interests	765
Total Preferred & Common Equity	745
Total Common Equity	745
Common Stock	517
Accumulated Other Comprehensive Income / (Loss)	-1.00
Other Equity Adjustments	229
Noncontrolling Interest	20

This table displays calculated financial ratios and metrics derived from Constellium's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.27%	-8.27%	22.54%	16.73%	-10.02%	1.87%	3.45%	26.08%	-8.12%	0.00%
EBITDA Growth	-14.46%	18.42%	-36.12%	81.20%	-18.20%	-16.63%	12.50%	37.73%	173.35%	0.00%
EBIT Growth	-28.28%	35.57%	-53.81%	258.74%	-46.64%	-38.11%	13.88%	44.55%	146.41%	0.00%
NOPAT Growth	-53.72%	-63.74%	59.09%	323.56%	-56.10%	-0.96%	220.72%	-1,178.89%	95.08%	0.00%
Net Income Growth	-61.78%	-50.16%	6.23%	1,527.88%	-128.91%	-66.97%	683.96%	-784.95%	99.30%	0.00%
EPS Growth	-63.11%	-50.95%	20.00%	1,266.67%	-136.59%	-70.07%	589.29%	-600.00%	0.00%	0.00%
Operating Cash Flow Growth	-30.32%	18.36%	-9.67%	-0.97%	-18.67%	564.11%	-60.70%	107.61%	115.44%	0.00%
Free Cash Flow Firm Growth	102.23%	-158.71%	685.85%	-492.79%	624.07%	130.44%	78.89%	69.57%	0.00%	0.00%
Invested Capital Growth	2.29%	439.00%	-120.56%	58.66%	-4.67%	10.14%	19.47%	17.22%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	12.79%	13.48%	11.29%	10.79%	10.03%	10.19%	9.46%	10.60%	11.28%	9.00%
EBITDA Margin	7.50%	8.22%	6.36%	12.21%	7.86%	8.65%	10.57%	9.72%	8.90%	-11.14%
Operating Margin	3.71%	4.93%	4.02%	7.87%	2.56%	4.71%	4.41%	5.12%	5.19%	-8.52%
EBIT Margin	3.35%	4.38%	2.97%	7.87%	2.56%	4.32%	7.11%	6.45%	5.63%	-11.14%
Profit (Net Income) Margin	0.82%	2.01%	3.69%	4.26%	-0.35%	1.08%	3.34%	-0.59%	-0.08%	-11.04%
Tax Burden Percent	44.44%	67.67%	210.00%	82.65%	50.00%	78.05%	85.59%	-63.27%	-6.15%	94.52%
Interest Burden Percent	54.88%	67.64%	59.29%	65.50%	-27.20%	32.16%	54.95%	14.50%	24.34%	104.85%
Effective Tax Rate	55.56%	32.33%	-110.00%	17.35%	0.00%	21.95%	14.41%	163.27%	106.15%	0.00%
Return on Invested Capital (ROIC)	4.88%	30.27%	51.64%	15.82%	4.71%	10.99%	12.70%	-12.46%	-2.12%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	1.39%	-85.91%	2.69%	10.15%	-0.66%	3.62%	11.40%	-4.63%	-1.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	3.29%	-9.97%	3.93%	272.12%	14.27%	-74.59%	-97.36%	20.03%	3.52%	0.00%
Return on Equity (ROE)	8.17%	20.30%	55.56%	287.93%	18.99%	-63.60%	-84.67%	7.58%	1.40%	0.00%
Cash Return on Invested Capital (CROIC)	2.62%	-118.83%	0.00%	-29.54%	9.49%	1.34%	-5.05%	-28.31%	-202.12%	0.00%
Operating Return on Assets (OROA)	5.09%	6.71%	4.81%	10.66%	3.14%	6.25%	10.36%	9.62%	7.05%	0.00%
Return on Assets (ROA)	1.24%	3.07%	5.99%	5.77%	-0.43%	1.57%	4.87%	-0.88%	-0.11%	0.00%
Return on Common Equity (ROCE)	7.92%	13.79%	8.21%	-1,144.63%	106.97%	-202.38%	-87.76%	7.72%	1.43%	0.00%
Return on Equity Simple (ROE_SIMPLE)	8.50%	21.87%	40.28%	95.62%	7.87%	-75.29%	-155.74%	9.48%	0.69%	0.00%
Net Operating Profit after Tax (NOPAT)	121	261	720	453	107	244	246	-204	-16	-324
NOPAT Margin	1.65%	3.34%	8.44%	6.50%	1.79%	3.67%	3.78%	-3.24%	-0.32%	-5.97%
Net Nonoperating Expense Percent (NNEP)	3.50%	116.19%	48.95%	5.66%	5.37%	7.37%	1.30%	-7.83%	-1.11%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	4.57%	9.78%	23.52%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	87.21%	86.52%	88.71%	89.21%	89.97%	89.81%	90.54%	89.40%	88.72%	94.10%
SG&A Expenses to Revenue	4.27%	4.05%	3.33%	4.19%	4.85%	4.67%	4.34%	4.72%	5.33%	4.90%
R&D to Revenue	0.67%	0.66%	0.54%	0.63%	0.80%	0.81%	0.70%	0.69%	0.65%	0.70%
Operating Expenses to Revenue	9.08%	8.55%	7.27%	2.93%	7.47%	5.49%	5.05%	5.48%	6.09%	14.91%
Earnings before Interest and Taxes (EBIT)	246	343	253	548	153	286	462	406	281	-605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	550	643	543	850	469	573	688	611	444	-605
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.14	4.01	5.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	2.68	5.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.21	0.37	0.20	0.36	0.32	0.27	0.14	0.00	0.00	0.00
Price to Earnings (P/E)	26.93	18.95	5.44	8.62	0.00	23.53	4.28	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.71%	5.28%	18.38%	11.60%	0.00%	4.25%	23.37%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.32	1.88	0.00	1.49	2.19	2.04	1.53	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.45	0.59	0.50	0.75	0.81	0.72	0.50	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	6.01	7.17	7.79	6.17	10.33	8.28	4.68	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	13.44	13.44	16.71	9.57	31.72	16.59	6.97	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	27.35	17.65	5.87	11.58	45.31	19.50	13.11	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	10.98	10.67	11.59	12.98	11.87	9.47	42.66	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	50.95	0.00	0.85	0.00	22.50	159.68	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.64	2.60	2.81	7.32	-23.67	-27.78	-18.87	-6.67	-4.33	0.00
Long-Term Debt to Equity	2.58	2.54	2.56	6.43	-22.76	-25.41	-18.87	-6.34	-4.14	0.00
Financial Leverage	2.37	0.12	1.46	26.80	-21.73	-20.61	-8.54	-4.33	-3.51	0.00
Leverage Ratio	6.58	6.61	9.28	49.90	-44.52	-40.56	-17.37	-8.59	-6.64	0.00
Compound Leverage Factor	3.61	4.47	5.50	32.68	12.11	-13.04	-9.55	-1.25	-1.62	0.00
Debt to Total Capital	72.51%	72.22%	73.73%	87.98%	104.41%	103.73%	105.60%	117.64%	130.03%	0.00%
Short-Term Debt to Total Capital	1.47%	1.54%	6.60%	10.66%	4.02%	8.83%	0.00%	5.86%	5.64%	0.00%
Long-Term Debt to Total Capital	71.04%	70.69%	67.13%	77.31%	100.39%	94.90%	105.60%	111.78%	124.39%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	14.67%	17.36%	18.34%	18.45%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.79%	0.90%	0.73%	0.70%	0.61%	0.48%	0.39%	0.44%	0.47%	0.00%
Common Equity to Total Capital	26.69%	26.88%	10.86%	-6.03%	-23.36%	-22.67%	-5.99%	-18.09%	-30.51%	0.00%
Debt to EBITDA	3.49	3.00	4.16	2.83	6.23	4.62	3.58	4.18	5.85	0.00
Net Debt to EBITDA	3.23	2.65	3.83	2.64	5.08	4.26	3.30	3.65	4.99	0.00
Long-Term Debt to EBITDA	3.42	2.94	3.79	2.49	5.99	4.23	3.58	3.97	5.59	0.00
Debt to NOPAT	15.87	7.38	3.14	5.32	27.33	10.88	10.01	-12.54	-163.03	0.00
Net Debt to NOPAT	14.70	6.53	2.89	4.95	22.31	10.03	9.25	-10.95	-139.05	0.00
Long-Term Debt to NOPAT	15.54	7.23	2.85	4.68	26.27	9.96	10.01	-11.92	-155.96	0.00
Altman Z-Score	2.05	2.33	1.76	2.27	1.62	1.69	2.04	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	3.06%	32.06%	85.23%	497.53%	-463.43%	-218.20%	-3.65%	-1.94%	-1.58%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.27	1.28	0.43	1.65	1.35	1.06	1.37	1.26	1.38	0.00
Quick Ratio	0.43	0.48	0.41	0.48	0.78	0.52	0.72	0.62	0.69	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	65	-2,909	4,954	-846	215	30	-98	-463	-1,521	0.00
Operating Cash Flow to CapEx	72.88%	118.03%	126.30%	160.81%	188.70%	164.94%	23.83%	57.97%	24.79%	0.00%
Free Cash Flow to Firm to Interest Expense	0.58	-26.21	48.10	0.00	0.00	0.15	-0.47	-1.48	-7.69	0.00
Operating Cash Flow to Interest Expense	2.71	3.89	3.54	0.00	0.00	2.58	0.36	0.62	0.47	0.00
Operating Cash Flow Less CapEx to Interest Expense	-1.01	0.59	0.74	0.00	0.00	1.02	-1.16	-0.45	-1.42	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.52	1.53	1.62	1.36	1.22	1.45	1.46	1.49	1.25	0.00
Accounts Receivable Turnover	14.42	14.13	12.64	10.97	11.61	11.01	11.08	14.35	13.36	0.00
Inventory Turnover	5.38	0.00	0.00	4.28	7.34	7.90	7.71	8.07	7.12	0.00
Fixed Asset Turnover	3.04	0.00	0.00	3.07	2.57	3.15	3.49	3.73	3.21	0.00
Accounts Payable Turnover	4.70	4.51	4.81	4.66	4.82	5.27	5.22	5.62	5.02	0.00
Days Sales Outstanding (DSO)	25.30	25.83	28.87	33.26	31.45	33.14	32.96	25.44	27.32	0.00
Days Inventory Outstanding (DIO)	67.84	0.00	0.00	85.34	49.75	46.20	47.32	45.24	51.26	0.00
Days Payable Outstanding (DPO)	77.60	80.94	75.96	78.27	75.72	69.28	69.88	64.89	72.77	0.00
Cash Conversion Cycle (CCC)	15.55	-55.11	-47.09	40.32	5.47	10.07	10.40	5.78	5.81	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,504	2,448	-722	3,512	2,214	2,322	2,108	1,765	1,505	0.00
Invested Capital Turnover	2.96	9.07	6.12	2.43	2.63	2.99	3.36	3.85	6.63	0.00
Increase / (Decrease) in Invested Capital	56	3,170	-4,234	1,298	-108	214	344	259	1,505	0.00
Enterprise Value (EV)	3,306	4,610	4,229	5,245	4,844	4,748	3,222	0.00	0.00	0.00
Market Capitalization	1,508	2,880	1,676	2,507	1,929	1,822	940	0.00	0.00	0.00
Book Value per Share	$4.81	$4.98	$2.35	($1.18)	($4.74)	($4.26)	($1.04)	($2.92)	$0.00	$0.00
Tangible Book Value per Share	$3.83	$3.97	($1.67)	($5.30)	($8.98)	($8.59)	($5.22)	($7.13)	$0.00	$0.00
Total Capital	2,645	2,671	3,063	2,739	2,797	2,554	2,331	2,172	1,997	0.00
Total Debt	1,918	1,929	2,258	2,410	2,921	2,650	2,462	2,555	2,596	0.00
Total Long-Term Debt	1,879	1,888	2,056	2,118	2,808	2,424	2,462	2,428	2,484	0.00
Net Debt	1,777	1,706	2,081	2,243	2,385	2,442	2,273	2,231	2,214	0.00
Capital Expenditures (CapEx)	413	366	289	251	216	304	317	332	373	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	286	254	-1,010	1,384	40	107	261	153	156	0.00
Debt-free Net Working Capital (DFNWC)	427	477	-832	1,551	577	313	449	476	521	0.00
Net Working Capital (NWC)	388	436	-1,034	1,259	464	88	449	348	408	0.00
Net Nonoperating Expense (NNE)	61	104	405	156	128	172	28	-166	-12	276
Net Nonoperating Obligations (NNO)	1,777	1,706	-1,527	3,183	2,337	2,417	2,239	2,148	2,105	0.00
Total Depreciation and Amortization (D&A)	304	300	290	302	316	287	225	205	163	0.00
Debt-free, Cash-free Net Working Capital to Revenue	3.90%	3.25%	-11.84%	19.88%	0.68%	1.61%	4.01%	2.43%	3.12%	0.00%
Debt-free Net Working Capital to Revenue	5.82%	6.10%	-9.76%	22.27%	9.67%	4.72%	6.89%	7.56%	10.44%	0.00%
Net Working Capital to Revenue	5.29%	5.57%	-12.12%	18.08%	7.78%	1.32%	6.89%	5.54%	8.18%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.38	$0.85	$2.10	$1.82	($0.15)	$0.43	$1.40	($0.28)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	143.52M	146.13M	143.63M	141.00M	138.74M	137.87M	136.00M	134.51M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.38	$0.84	$2.06	$1.75	($0.15)	$0.41	$1.37	($0.28)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	143.52M	149.24M	146.61M	147.17M	138.74M	137.87M	136.00M	134.51M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	143.52M	146.82M	144.30M	141.68M	139.96M	137.87M	136.00M	134.51M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	190	261	240	453	107	244	246	229	185	30
Normalized NOPAT Margin	2.60%	3.34%	2.81%	6.50%	1.79%	3.67%	3.78%	3.64%	3.70%	0.55%
Pre Tax Income Margin	1.84%	2.96%	1.76%	5.15%	-0.70%	1.39%	3.90%	0.94%	1.37%	-11.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.22	3.09	2.46	0.00	0.00	1.47	2.22	1.30	1.42	0.00
NOPAT to Interest Expense	1.09	2.35	6.99	0.00	0.00	1.25	1.18	-0.65	-0.08	0.00
EBIT Less CapEx to Interest Expense	-1.50	-0.21	-0.35	0.00	0.00	-0.09	0.70	0.24	-0.47	0.00
NOPAT Less CapEx to Interest Expense	-2.63	-0.94	4.19	0.00	0.00	-0.31	-0.34	-1.71	-1.97	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.33%	1.91%	0.63%	0.76%	0.00%	6.25%	0.00%	0.00%	-50.00%	0.00%
Augmented Payout Ratio	140.00%	1.91%	0.63%	0.76%	0.00%	6.25%	0.00%	0.00%	-50.00%	0.00%

This table displays calculated financial ratios and metrics derived from Constellium's official financial filings.

Metric	Q1 2025
Period end date	3/31/2025
Growth Metrics	-
Revenue Growth	5.27%
EBITDA Growth	26.52%
EBIT Growth	56.14%
NOPAT Growth	4.75%
Net Income Growth	72.73%
EPS Growth	85.71%
Operating Cash Flow Growth	56.76%
Free Cash Flow Firm Growth	0.00%
Invested Capital Growth	0.00%
Revenue Q/Q Growth	0.00%
EBITDA Q/Q Growth	0.00%
EBIT Q/Q Growth	0.00%
NOPAT Q/Q Growth	0.00%
Net Income Q/Q Growth	0.00%
EPS Q/Q Growth	0.00%
Operating Cash Flow Q/Q Growth	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%
Invested Capital Q/Q Growth	0.00%
Profitability Metrics	-
Gross Margin	13.29%
EBITDA Margin	8.44%
Operating Margin	4.75%
EBIT Margin	4.50%
Profit (Net Income) Margin	1.92%
Tax Burden Percent	61.29%
Interest Burden Percent	69.66%
Effective Tax Rate	38.71%
Return on Invested Capital (ROIC)	16.71%
ROIC Less NNEP Spread (ROIC-NNEP)	14.56%
Return on Net Nonoperating Assets (RNNOA)	34.74%
Return on Equity (ROE)	51.45%
Cash Return on Invested Capital (CROIC)	0.00%
Operating Return on Assets (OROA)	6.47%
Return on Assets (ROA)	2.76%
Return on Common Equity (ROCE)	50.11%
Return on Equity Simple (ROE_SIMPLE)	10.20%
Net Operating Profit after Tax (NOPAT)	58
NOPAT Margin	2.91%
Net Nonoperating Expense Percent (NNEP)	2.15%
Return On Investment Capital (ROIC_SIMPLE)	2.13%
Cost of Revenue to Revenue	86.71%
SG&A Expenses to Revenue	3.94%
R&D to Revenue	0.66%
Operating Expenses to Revenue	8.54%
Earnings before Interest and Taxes (EBIT)	89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	167
Valuation Ratios	-
Price to Book Value (P/BV)	1.94
Price to Tangible Book Value (P/TBV)	2.39
Price to Revenue (P/Rev)	0.19
Price to Earnings (P/E)	20.11
Dividend Yield	0.00%
Earnings Yield	4.97%
Enterprise Value to Invested Capital (EV/IC)	1.27
Enterprise Value to Revenue (EV/Rev)	0.44
Enterprise Value to EBITDA (EV/EBITDA)	5.63
Enterprise Value to EBIT (EV/EBIT)	11.85
Enterprise Value to NOPAT (EV/NOPAT)	24.87
Enterprise Value to Operating Cash Flow (EV/OCF)	10.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00
Leverage & Solvency	-
Debt to Equity	2.54
Long-Term Debt to Equity	2.49
Financial Leverage	2.39
Leverage Ratio	6.76
Compound Leverage Factor	4.71
Debt to Total Capital	71.75%
Short-Term Debt to Total Capital	1.29%
Long-Term Debt to Total Capital	70.46%
Preferred Equity to Total Capital	0.00%
Noncontrolling Interests to Total Capital	0.74%
Common Equity to Total Capital	27.51%
Debt to EBITDA	3.32
Net Debt to EBITDA	3.12
Long-Term Debt to EBITDA	3.26
Debt to NOPAT	14.67
Net Debt to NOPAT	13.78
Long-Term Debt to NOPAT	14.41
Altman Z-Score	1.79
Noncontrolling Interest Sharing Ratio	2.61%
Liquidity Ratios	-
Current Ratio	1.24
Quick Ratio	0.52
Cash Flow Metrics	-
Free Cash Flow to Firm (FCFF)	-2,532
Operating Cash Flow to CapEx	84.06%
Free Cash Flow to Firm to Interest Expense	-93.79
Operating Cash Flow to Interest Expense	2.15
Operating Cash Flow Less CapEx to Interest Expense	-0.41
Efficiency Ratios	-
Asset Turnover	1.44
Accounts Receivable Turnover	9.09
Inventory Turnover	5.07
Fixed Asset Turnover	3.03
Accounts Payable Turnover	3.89
Days Sales Outstanding (DSO)	40.16
Days Inventory Outstanding (DIO)	72.01
Days Payable Outstanding (DPO)	93.81
Cash Conversion Cycle (CCC)	18.36
Capital & Investment Metrics	-
Invested Capital	2,590
Invested Capital Turnover	5.74
Increase / (Decrease) in Invested Capital	2,590
Enterprise Value (EV)	3,293
Market Capitalization	1,448
Book Value per Share	$5.19
Tangible Book Value per Share	$4.22
Total Capital	2,708
Total Debt	1,943
Total Long-Term Debt	1,908
Net Debt	1,825
Capital Expenditures (CapEx)	69
Debt-free, Cash-free Net Working Capital (DFCFNWC)	345
Debt-free Net Working Capital (DFNWC)	463
Net Working Capital (NWC)	428
Net Nonoperating Expense (NNE)	20
Net Nonoperating Obligations (NNO)	1,825
Total Depreciation and Amortization (D&A)	78
Debt-free, Cash-free Net Working Capital to Revenue	4.64%
Debt-free Net Working Capital to Revenue	6.23%
Net Working Capital to Revenue	5.76%
Earnings Adjustments	-
Adjusted Basic Earnings per Share	$0.26
Adjusted Weighted Average Basic Shares Outstanding	142.92M
Adjusted Diluted Earnings per Share	$0.26
Adjusted Weighted Average Diluted Shares Outstanding	142.92M
Adjusted Basic & Diluted Earnings per Share	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	142.92M
Normalized Net Operating Profit after Tax (NOPAT)	58
Normalized NOPAT Margin	2.91%
Pre Tax Income Margin	3.13%
Debt Service Ratios	-
EBIT to Interest Expense	3.30
NOPAT to Interest Expense	2.13
EBIT Less CapEx to Interest Expense	0.74
NOPAT Less CapEx to Interest Expense	-0.42
Payout Ratios	-
Dividend Payout Ratio	7.89%
Augmented Payout Ratio	122.37%

Frequently Asked Questions About Constellium's Financials

When does Constellium's financial year end?

According to the most recent income statement we have on file, Constellium's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Constellium's net income changed over the last 9 years?

Constellium's net income appears to be on an upward trend, with a most recent value of $60 million in 2024, falling from -$599.77 million in 2015. The previous period was $157 million in 2023. Check out Constellium's forecast to explore projected trends and price targets.

What is Constellium's operating income?

Constellium's total operating income in 2024 was $272 million, based on the following breakdown:

Total Gross Profit: $938 million
Total Operating Expenses: $666 million

How has Constellium revenue changed over the last 9 years?

Over the last 9 years, Constellium's total revenue changed from $5.43 billion in 2015 to $7.34 billion in 2024, a change of 35.1%.

How much debt does Constellium have?

Constellium's total liabilities were at $4.01 billion at the end of 2024, a 4.4% decrease from 2023, and a 12.6% decrease since 2016.

How much cash does Constellium have?

In the past 8 years, Constellium's cash and equivalents has ranged from $141 million in 2024 to $536.28 million in 2020, and is currently $141 million as of their latest financial filing in 2024.

How has Constellium's book value per share changed over the last 9 years?

Over the last 9 years, Constellium's book value per share changed from 0.00 in 2015 to 4.81 in 2024, a change of 480.9%.

Related Companies

This page (NYSE:CSTM) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Constellium (CSTM) Financials

Frequently Asked Questions About Constellium's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Constellium (CSTM) Financials

Annual Income Statements for Constellium

Quarterly Income Statements for Constellium

Annual Cash Flow Statements for Constellium

Quarterly Cash Flow Statements for Constellium

Annual Balance Sheets for Constellium

Quarterly Balance Sheets for Constellium

Annual Metrics And Ratios for Constellium

Quarterly Metrics And Ratios for Constellium

Frequently Asked Questions About Constellium's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools